<DOC>
	<DOCNO>NCT02643719</DOCNO>
	<brief_summary>Randomized pilot feasibility study evaluate impact introduce behavioral treatment migraine Emergency Department ( ED ) prescribe migraine preventive medication ED . The study examine effect treatment , individually combination , pain severity headache-related disability . This study design examine feasibility compare four intervention ED patient present migraine . Group 1 : Starting topiramate ; Group 2 : Doing brief behavioral intervention ; Group 3 : Treating combination therapy topiramate behavioral intervention ; Group 4 : Standard Care .</brief_summary>
	<brief_title>Migraine Treatment ED</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>age 18 year 65 year age primary diagnosis migraine base International Classification headache disorder 3 beta criterion migraine 3 days/month . Cognitive Behavioral Therapy ( CBT ) , biofeedback relaxation therapy past year medication use migraine prevention ( topiramate , propranolol , valproic acid , amitriptyline/nortriptyline/imipramine/desipramine , botulinum toxin , SNRI , angiotensinconverting enzyme inhibitor ( ACEI ) ARB ) cognitive deficit physical problem potential interfere behavioral therapy substance alcohol abuse determine selfreport prior documentation medical record .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>migraine</keyword>
	<keyword>topiramate</keyword>
</DOC>